Bendamustine treatment of haematological malignancies: significant risks of opportunistic viral, fungal and bacterial infections
Objectives Bendamustine is a standard treatment for low-grade B-cell lymphomas, and considered safe in clinical trials. Its safety in routine practice might be different.Methods We retrospectively analyzed the infection complications in an unselected cohort of patients treated with bendamustine over...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis Group
2022-12-01
|
| Schriftenreihe: | Hematology |
| Schlagworte: | |
| Online-Zugang: | https://www.tandfonline.com/doi/10.1080/16078454.2022.2072065 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|